Mapping-Guided Ablation for Persistent Atrial Fibrillation [MAP-AF] Trial

Not Applicable

• Conditions: atrial fibrillation

• Registration Number: JPRN-UMIN000037569
• Lead Sponsor: Tokyo Medical and Dental University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-12-01
• Study Completion: 2023-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 206

Inclusion Criteria

Not provided

Exclusion Criteria

1) Sinus rhythm from 3-month before the enrollment of the study to the beginning of the ablation procedure. 2) Prior catheter ablation for atrial fibrillation or uncommon atrial flutter. 3) Prior surgical Maze procedure. 4) Patients in whom cardiac implantable electronic devices were implanted. 5) Patients who were taking aimodarone within 1-year from the enrollment of the study. 6) Untreated thyroild dysfunction. 7) End-stage renal disease (eGFR<15 or requirement of hemodialysis).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Freedom from atrial fibrillation, atrial flutter or atrial tachycardia after a single catheter ablation procedure.

Secondary Outcome Measures

Name	Time	Method
Freedom from atrial fibrillation, atrial flutter or atrial tachycardia after multiple catheter ablation procedures. Freedom from persistent atrial fibrillation, persistent atrial flutter or persistent atrial tachycardia after a single catheter ablation procedure.